• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房患者血浆中洋地黄样免疫反应性物质:与器官功能障碍的关系

Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.

作者信息

Howarth D M, Sampson D C, Hawker F H, Young A

机构信息

Royal Prince Alfred Hospital, Sydney, N.S.W.

出版信息

Anaesth Intensive Care. 1990 Feb;18(1):45-52. doi: 10.1177/0310057X9001800108.

DOI:10.1177/0310057X9001800108
PMID:2159733
Abstract

Digoxin-like immunoreactive substances are an endogenous group of compounds that cross-react in conventional immunoassays for digoxin. Plasma digoxin-like immunoreactive substance concentrations were estimated using the Abbott TDxll fluorescence polarisation immunoassay kit for digoxin. Digoxin-like immunoreactive substances were measured in one hundred consecutive Intensive Care Unit (ICU) patients who were not treated with digoxin. One hundred healthy blood donors were used as controls. Thirty of the ICU patients had plasma digoxin-like immunoreactive substance concentrations greater than or equal to the greatest value found in the control group (0.22 nmol/l). In the ICU group the median value was 0.17 nmol/l and the range zero to 1.69 nmol/l. In the control group the median was less than the limit of detection of the assay, and the range zero to 0.22 nmol/l. Sixteen ICU patients had coexisting renal and hepatic dysfunction and this group had a median digoxin-like immunoreactive substance concentration of 0.21 nmol/l (range zero to 1.69 nmol/l), while 38 patients with hepatic dysfunction and normal renal function had a median concentration of 0.17 nmol/l (range zero to 0.77 nmol/l). In contrast four patients with renal dysfunction only had a median concentration of 0.05 nmol/l (range zero to 0.34 nmol/l). The remaining forty-two patients had neither hepatic nor renal dysfunction and this group had a median concentration of 0.15 nmol/l (range zero to 0.36 nmol/l). This study has identified the critically ill as a group of patients who exhibit measurable plasma digoxin-like immunoreactive substances using the most commonly used kit for analysis of digoxin.

摘要

地高辛样免疫反应性物质是一类内源性化合物,它们在传统的地高辛免疫测定中会发生交叉反应。使用雅培TDxll地高辛荧光偏振免疫测定试剂盒估算血浆地高辛样免疫反应性物质的浓度。对100例未接受地高辛治疗的重症监护病房(ICU)连续患者测量了地高辛样免疫反应性物质。100名健康献血者作为对照。30例ICU患者的血浆地高辛样免疫反应性物质浓度大于或等于对照组中发现的最大值(0.22 nmol/l)。ICU组的中位数为0.17 nmol/l,范围为0至1.69 nmol/l。对照组的中位数低于该测定的检测限,范围为0至0.22 nmol/l。16例ICU患者同时存在肝肾功能不全,该组地高辛样免疫反应性物质浓度中位数为0.21 nmol/l(范围为0至1.69 nmol/l),而38例肝功能不全但肾功能正常的患者浓度中位数为0.17 nmol/l(范围为0至0.77 nmol/l)。相比之下,仅4例肾功能不全患者的浓度中位数为0.05 nmol/l(范围为0至0.34 nmol/l)。其余42例患者既无肝功能不全也无肾功能不全,该组浓度中位数为0.15 nmol/l(范围为0至0.36 nmol/l)。本研究已确定危重症患者是使用最常用的地高辛分析试剂盒可检测出血浆地高辛样免疫反应性物质的一组患者。

相似文献

1
Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.重症监护病房患者血浆中洋地黄样免疫反应性物质:与器官功能障碍的关系
Anaesth Intensive Care. 1990 Feb;18(1):45-52. doi: 10.1177/0310057X9001800108.
2
Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Nephron. 1986;44(2):108-10. doi: 10.1159/000183976.
3
[Levels of ACTH and endogenous-digitalis-like substances in human blood].
Sb Lek. 1989 Sep;91(8-9):265-73.
4
Digoxin-like immunoreactive substance in pregnancy.
Am J Obstet Gynecol. 1987 Sep;157(3):660-4. doi: 10.1016/s0002-9378(87)80024-8.
5
Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
Hepatology. 1988 Jan-Feb;8(1):93-7. doi: 10.1002/hep.1840080119.
6
Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Clin Pharm. 1986 Oct;5(10):810-6.
7
Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children.内源性洋地黄样物质对儿童高浓度地高辛检测结果判读的影响
J Pediatr. 1990 Aug;117(2 Pt 1):321-5. doi: 10.1016/s0022-3476(05)80555-4.
8
Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.在人类中鉴定内源性化合物作为地高辛样免疫反应因子的标准。
Clin Chim Acta. 1988 Jun 30;175(1):67-77. doi: 10.1016/0009-8981(88)90036-8.
9
A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Ann Clin Lab Sci. 1989 May-Jun;19(3):168-74.
10
[The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
Anasth Intensivther Notfallmed. 1990 Jun;25(3):235-6.